Content Library

2019 Presentations

From Human Genetics To Actionable Targets

Daniel Hoeppner, Astellas

Adjunctive Therapies in the
Treatment of Primary Symptoms
of Schizophrenia

Jim Cassella, Concert Pharmaceuticals

KMO Inhibitors for Depression
Co-Morbid with Chronic Inflammatory Disease

Stevin Zorn, MindImmune Therapeutics

An Overview of Developing PET/SPECT Ligands for CNS Drug Research & Development, An Application of Nuclear Imaging Techniques

Shil Patel, Codiak BioSciences

2018 Presentations


A Circuits and Symptoms Approach to Drug Discovery in Psychiatry

Boehringer Ingelheim


Exploring the gaps in neuropsychiatric research



The Impact of Genetics on Future Drug Discovery in Psychiatric Disorders

Astellas Pharma